The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus Nephritis

Clin J Am Soc Nephrol. 2022 Nov;17(11):1583-1585. doi: 10.2215/CJN.11340922. Epub 2022 Oct 27.
No abstract available

Keywords: belimumab; immunosuppression; systemic lupus erythematosus; voclosporin.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic*
  • Lupus Nephritis* / drug therapy
  • Treatment Outcome

Substances

  • Immunosuppressive Agents